Hand, Foot And Mouth Disease Market – Pipeline Review, H1 2016

Summary

“Orbis Research Add’s New Report to its Database, ‘Hand, Foot And Mouth Disease – Pipeline Review, H1 2016’, provides an overview of the Hand, Foot And Mouth Disease pipeline landscape”.

Description

The report provides comprehensive information on the therapeutics under development for Hand, Foot And Mouth Disease , complete with analysis by stage of development,
drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the
therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved
in therapeutic development for Hand, Foot And Mouth Disease and features dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using
data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings,
investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report
undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various
dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective
counter strategies to gain competitive advantage.

Request a sample of this report @ http://www.orbisresearch.com/contacts/request-sample/145310

Scope

– The report provides a snapshot of the global therapeutic landscape of Hand, Foot And Mouth Disease
– The report reviews pipeline therapeutics for Hand, Foot And Mouth Disease by companies and universities/research institutes based on information derived from company
and industry-specific sources
– The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
– The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration
details & other developmental activities
– The report reviews key players involved Hand, Foot And Mouth Disease therapeutics and enlists all their major and minor projects
– The report assesses Hand, Foot And Mouth Disease therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
– The report summarizes all the dormant and discontinued pipeline projects
– The report reviews latest news related to pipeline therapeutics for Hand, Foot And Mouth Disease

Purchase a copy of Hand, Foot And Mouth Disease-Pipeline Review, H1 2016 @ http://www.orbisresearch.com/contact/purchase/145310

Reasons to buy

– Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
– Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
– Identify and understand important and diverse types of therapeutics under development for Hand, Foot And Mouth Disease
– Identify potential new clients or partners in the target demographic
– Develop strategic initiatives by understanding the focus areas of leading companies
– Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
– Devise corrective measures for pipeline projects by understanding Hand, Foot And Mouth Disease pipeline depth and focus of Indication therapeutics
– Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business
potential and scope
– Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

Companies Mentioned

CJ HealthCare Corp.
Sentinext Therapeutics Sdn Bhd
Takeda Pharmaceutical Company Limited

Some Points From TOC:

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 4

Introduction 5
Global Markets Direct Report Coverage 5
Hand, Foot And Mouth Disease Overview 6
Therapeutics Development 7
Pipeline Products for Hand, Foot And Mouth Disease – Overview 7
Pipeline Products for Hand, Foot And Mouth Disease – Comparative Analysis 8
Hand, Foot And Mouth Disease – Therapeutics under Development by Companies 9
Hand, Foot And Mouth Disease – Therapeutics under Investigation by Universities/Institutes 10
Hand, Foot And Mouth Disease – Pipeline Products Glance 11
Clinical Stage Products 11
Early Stage Products 12
Hand, Foot And Mouth Disease – Products under Development by Companies 13
Hand, Foot And Mouth Disease – Products under Investigation by Universities/Institutes 14
Hand, Foot And Mouth Disease – Companies Involved in Therapeutics Development 15
CJ HealthCare Corp. 15
Sentinext Therapeutics Sdn Bhd 16
Takeda Pharmaceutical Company Limited 17
Hand, Foot And Mouth Disease – Therapeutics Assessment 18
Assessment by Monotherapy Products 18
Assessment by Combination Products 19
Assessment by Route of Administration 20

About Us:

Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.

Contact Information:

Hector Costello

Senior Manager – Client Engagements

4144N Central Expressway,

Suite 600, Dallas,

Texas – 75204, U.S.A.

Phone No.: +1 (214) 884-6817; +9164101019

Email ID: sales@orbisresearch.com

Leave a Reply

Designed by CyFocus.com
Powered by CyFocus.net